Kezar Life Sciences inventory hits 52-week low at $0.53 By Investing.com
Kezar Life Sciences Inc. (NASDAQ:) inventory has reached a 52-week low, touching…
Roivant Sciences re-elects administrators, ratifies EY as auditor By Investing.com
Roivant Sciences Ltd. (NASDAQ:), a pharmaceutical firm, introduced the outcomes of its…
